Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients.
DISCUSSION: In contrast to the general population, hyperuricemia is not associated with increased mortality in patients undergoing hemodialysis. Moreover, xanthine oxidase inhibition was not associated with a survival benefit in this analysis. These data do not support the use of SUA lowering medication in hemodialysis patients with asymptomatic hyperuricemia.
PMID: 33076736 [PubMed - in process]
Source: Renal Failure - Category: Urology & Nephrology Tags: Ren Fail Source Type: research
More News: Allopurinol | Cardiology | Cardiovascular | Dialysis | Heart | Hemodialysis | Renal Failure | Urology & Nephrology